|
1
|
Petersmann A, Nauck M, Müller-Wieland D,
Kerner W, Müller UA, Landgraf R, Freckmann G and Heinemann L:
Definition, classification and diagnosis of diabetes mellitus. Exp
Clin Endocrinol Diabetes. 126:406–410. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Burgos-Morón E, Abad-Jiménez Z, Marañón
AM, Iannantuoni F, Escribano-López I, López-Domènech S, Salom C,
Jover A, Mora V, Roldan I, et al: Relationship between oxidative
stress, er stress, and inflammation in type 2 diabetes: The battle
continues. J Clin Med. 8(1385)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Moldogazieva NT, Mokhosoev IM, Mel'nikova
TI, Porozov YB and Terentiev AA: Oxidative stress and advanced
lipoxidation and glycation end products (ALEs and AGEs) in aging
and age-related diseases. Oxid Med Cell Longev.
2019(3085756)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Asthana S, Mallick B, Alexandrescu AT and
Jha S: IAPP in type II diabetes: Basic research on structure,
molecular interactions, and disease mechanisms suggests potential
intervention strategies. Biochim Biophys Acta Biomembr.
1860:1765–1782. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hieronymus L and Griffin S: Role of amylin
in type 1 and type 2 diabetes. Diabetes Educ. 41 (Suppl 1):47S–56S.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Takenaka N, Araki N and Satoh T:
Involvement of the protein kinase Akt2 in insulin-stimulated Rac1
activation leading to glucose uptake in mouse skeletal muscle. PLoS
One. 14(e0212219)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chadt A and Al-Hasani H: Glucose
transporters in adipose tissue, liver, and skeletal muscle in
metabolic health and disease. Pflugers Arch. 472:1273–1298.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pearce NJ, Arch JR, Clapham JC, Coghlan
MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA,
et al: Development of glucose intolerance in male transgenic mice
overexpressing human glycogen synthase kinase-3beta on a
muscle-specific promoter. Metabolism. 53:1322–1330. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
MacAulay K and Woodgett JR: Targeting
glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2
diabetes. Expert Opin Ther Targets. 12:1265–1274. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Salehi B, Ata A, V Anil Kumar N, Sharopov
F, Ramírez-Alarcón K, Ruiz-Ortega A, Abdulmajid Ayatollahi S, Tsouh
Fokou PV, Kobarfard F, Amiruddin Zakaria Z, et al: Antidiabetic
potential of medicinal plants and their active components.
Biomolecules. 9(551)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dorri M, Hashemitabar S and Hosseinzadeh
H: Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective
agent against natural or chemical toxicities: A review. Drug Chem
Toxicol. 41:338–351. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cao H, Ou J, Chen L, Zhang Y, Szkudelski
T, Delmas D, Daglia M and Xiao J: Dietary polyphenols and type 2
diabetes: Human study and clinical trial. Crit Rev Food Sci Nutr.
59:3371–3379. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sun C, Zhao C, Guven EC, Paoli P,
Simal-Gandara J, Ramkumar KM, Wang S, Buleu F, Pah A, Turi V, et
al: Dietary polyphenols as antidiabetic agents: Advances and
opportunities. Food Frontiers. 1:18–44. 2020.
|
|
14
|
Wang TK, Xu S, Li S and Zhang Y:
Proanthocyanidins should be a candidate in the treatment of cancer,
cardiovascular diseases and lipid metabolic disorder. Molecules.
25(5971)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Koutsos A, Riccadonna S, Ulaszewska MM,
Franceschi P, Trošt K, Galvin A, Braune T, Fava F, Perenzoni D,
Mattivi F, et al: Two apples a day lower serum cholesterol and
improve cardiometabolic biomarkers in mildly hypercholesterolemic
adults: A randomized, controlled, crossover trial. Am J Clin Nutr.
111:307–318. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yokozawa T, Cho EJ, Park CH and Kim JH:
Protective effect of proanthocyanidin against diabetic oxidative
stress. Evid Based Complement Alternat Med.
2012(623879)2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mabhida SE, Johnson R, Ndlovu M, Louw J,
Opoku A and Mosa RA: Molecular basis of the anti-hyperglycemic
activity of RA-3 in hyperlipidemic and streptozotocin-induced type
2 diabetes in rats. Diabetol Metab Syndr. 11(27)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cheung DY, Kim JI, Park SH and Kim JK:
Proanthocyanidin from grape seed extracts protects
indomethacin-induced small intestinal mucosal injury. Gastroenterol
Res Pract. 2014(618068)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Qin B, Nagasaki M, Ren M, Bajotto G,
Oshida Y and Sato Y: Cinnamon extract (traditional herb)
potentiates in vivo insulin-regulated glucose utilization via
enhancing insulin signaling in rats. Diabetes Res Clin Pract.
62:139–148. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Trinder P: Determination of blood glucose
using an oxidase-peroxidase system with a non-carcinogenic
chromogen. J Clin Pathol. 22:158–161. 1969.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Savoldi R, Prandini BD and Donisi C:
Enzymatic determination of total serum cholesterol by
4-aminophenazone-phenol: Manual and automatic method (author's
translation). Quad Sclavo Diagn. 12:238–247. 1976.PubMed/NCBI(In Italian).
|
|
22
|
Nagele U, Hagele EO, Sauer G, Wiedemann E,
Lehmann P, Wahlefeld AW and Gruber W: Reagent for the enzymatic
determination of serum total triglycerides with improved lipolytic
efficiency. J Clin Chem Clin Biochem. 22:165–174. 1984.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Austin GE, Maznicki E and Sgoutas D:
Comparison of phosphotungstate and dextran sulfate-Mg2+
precipitation procedure for determination of high density
lipoprotein cholesterol. Clin Biochem. 17:166–169. 1984.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Silva JAD, Souza ECF, Echazú Böschemeier
AG, Costa CCMD, Bezerra HS and Feitosa EELC: Diagnosis of diabetes
mellitus and living with a chronic condition: Participatory study.
BMC Public Health. 18(699)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jiang S, Young JL, Wang K, Qian Y and Cai
L: Diabetic-induced alterations in hepatic glucose and lipid
metabolism: The role of type 1 and type 2 diabetes mellitus
(Review). Mol Med Rep. 22:603–611. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zonszein J and Groop PH: Strategies for
diabetes management: Using newer oral combination therapies early
in the disease. Diabetes Ther. 7:621–639. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
I S, Sobczak A, A Blindauer C and J
Stewart A: Changes in plasma free fatty acids associated with
type-2 diabetes. Nutrients. 11(2022)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huang X, Liu G, Guo J and Su Z: The
PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci.
14:1483–1496. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yang H, Cao Q, Xiong X, Zhao P, Shen D,
Zhang Y and Zhang N: Fluoxetine regulates glucose and lipid
metabolism via the PI3K-AKT signaling pathway in diabetic rats. Mol
Med Rep. 22:3073–3080. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Maffei A, Lembo G and Carnevale D:
PI3Kinases in diabetes mellitus and its related complications. Int
J Mol Sci. 19(4098)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yogalakshmi B, Bhuvaneswari S, Sreeja S
and Anuradha CV: Grape seed proanthocyanidins and metformin act by
different mechanisms to promote insulin signaling in rats fed high
calorie diet. J Cell Commun Signal. 8:13–22. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Santos HO and da Silva GAR: To what extent
does cinnamon administration improve the glycemic and lipid
profiles? Clin Nutr ESPEN. 27:1–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sun Q, Jia N, Li X, Yang J and Chen G:
Grape seed proanthocyanidins ameliorate neuronal oxidative damage
by inhibiting GSK-3β-dependent mitochondrial permeability
transition pore opening in an experimental model of sporadic
Alzheimer's disease. Aging (Albany NY). 11:4107–4124.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ogawa A, Harris V, McCorkle SK, Unger RH
and Luskey KL: Amylin secretion from the rat pancreas and its
selective loss after streptozotocin treatment. J Clin Invest.
85:973–976. 1990.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang XX, Pan YH, Huang YM and Zhao HL:
Neuroendocrine hormone amylin in diabetes. World J Diabetes.
7:189–197. 2016.PubMed/NCBI View Article : Google Scholar
|
